Discontinuation report ATROVENT NASAL SPRAY
Report ID | 64493 |
Drug Identification Number | 02163705 |
Brand name | ATROVENT NASAL SPRAY |
Common or Proper name | ATROVENT Nasal Spray 0.03%, 345 doses - 21 mcg |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | IPRATROPIUM BROMIDE |
Strength(s) | 21MCG |
Dosage form(s) | SOLUTION |
Route of administration | NASAL |
Packaging size | 30ml |
ATC code | R01AX |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2018-10-04 |
Actual discontinuation date | 2018-10-04 |
Remaining supply date | 2018-10-04 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-10-17 | French | Compare |
v3 | 2018-10-17 | English | Compare |
v2 | 2018-10-17 | French | Compare |
v1 | 2018-10-17 | English | Compare |
Showing 1 to 4 of 4